​

Qiagen (QGEN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Qiagen Revenue Highlights

Latest Revenue (Y)

$1.97B

Latest Revenue (Q)

$458.80M

Main Segment (Y)

Diagnostic Solutions

Main Geography (Y)

Total Americas

Qiagen Revenue by Period

Qiagen Revenue by Year

DateRevenueChange
2023-12-31$1.97B-8.23%
2022-12-31$2.14B-4.89%
2021-12-31$2.25B20.39%
2020-12-31$1.87B22.53%
2019-12-31$1.53B1.64%
2018-12-31$1.50B5.95%
2017-12-31$1.42B5.95%
2016-12-31$1.34B4.45%
2015-12-31$1.28B-4.74%
2014-12-31$1.34B3.29%
2013-12-31$1.30B3.79%
2012-12-31$1.25B7.24%
2011-12-31$1.17B7.57%
2010-12-31$1.09B7.69%
2009-12-31$1.01B13.09%
2008-12-31$892.98M37.43%
2007-12-31$649.77M39.50%
2006-12-31$465.78M16.91%
2005-12-31$398.39M4.67%
2004-12-31$380.63M8.32%
2003-12-31$351.40M17.68%
2002-12-31$298.61M13.21%
2001-12-31$263.77M29.28%
2000-12-31$204.03M41.73%
1999-12-31$143.96M30.64%
1998-12-31$110.20M48.32%
1997-12-31$74.30M37.08%
1996-12-31$54.20M46.49%
1995-12-31$37.00M-

Qiagen generated $1.97B in revenue during NA 2023, up -8.23% compared to the previous quarter, and up 130.86% compared to the same period a year ago.

Qiagen Revenue by Quarter

DateRevenueChange
2024-03-31$458.80M-9.89%
2023-12-31$509.16M6.99%
2023-09-30$475.89M-3.83%
2023-06-30$494.86M1.95%
2023-03-31$485.40M-2.53%
2022-12-31$497.98M-0.33%
2022-09-30$499.63M-3.08%
2022-06-30$515.51M-17.96%
2022-03-31$628.39M7.90%
2021-12-31$582.40M8.91%
2021-09-30$534.75M-5.74%
2021-06-30$567.31M0.02%
2021-03-31$567.21M-0.71%
2020-12-31$571.23M18.08%
2020-09-30$483.76M9.14%
2020-06-30$443.25M19.12%
2020-03-31$372.10M-10.01%
2019-12-31$413.47M8.04%
2019-09-30$382.69M0.28%
2019-06-30$381.61M9.45%
2019-03-31$348.65M-13.52%
2018-12-31$403.17M6.68%
2018-09-30$377.91M0.19%
2018-06-30$377.20M9.79%
2018-03-31$343.57M-13.43%
2017-12-31$396.86M9.04%
2017-09-30$363.98M4.29%
2017-06-30$348.99M13.42%
2017-03-31$307.71M-16.05%
2016-12-31$366.51M8.22%
2016-09-30$338.69M1.28%
2016-06-30$334.41M12.08%
2016-03-31$298.38M-14.39%
2015-12-31$348.54M10.80%
2015-09-30$314.56M-1.53%
2015-06-30$319.46M7.05%
2015-03-31$298.43M-17.20%
2014-12-31$360.41M7.12%
2014-09-30$336.46M1.70%
2014-06-30$330.84M4.34%
2014-03-31$317.07M-12.19%
2013-12-31$361.08M12.10%
2013-09-30$322.11M2.19%
2013-06-30$315.21M3.83%
2013-03-31$303.58M-12.40%
2012-12-31$346.53M13.88%
2012-09-30$304.29M-0.95%
2012-06-30$307.21M3.64%
2012-03-31$296.42M-11.36%
2011-12-31$334.42M15.76%
2011-09-30$288.88M2.38%
2011-06-30$282.18M6.78%
2011-03-31$264.26M-7.61%
2010-12-31$286.03M4.27%
2010-09-30$274.32M4.42%
2010-06-30$262.72M-0.62%
2010-03-31$264.36M-8.55%
2009-12-31$289.08M11.33%
2009-09-30$259.66M8.12%
2009-06-30$240.16M8.70%
2009-03-31$220.93M-6.85%
2008-12-31$237.18M2.76%
2008-09-30$230.80M5.93%
2008-06-30$217.89M5.21%
2008-03-31$207.11M-1.48%
2007-12-31$210.22M-

Qiagen generated $458.80M in revenue during Q1 2024, up -9.89% compared to the previous quarter, and up 92.13% compared to the same period a year ago.

Qiagen Revenue Breakdown

Qiagen Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Genomics / NGS$233.61M$238.91M$224.80M$245.07M$165.57M
PCR / Nucleic Acid Amplification$300.47M$300.20M$390.80M$433.97M$363.55M
Product and Service, Other$53.22M$65.58M$68.11M$83.22M$76.60M
Sample Technologies$642.03M$662.99M$796.93M$850.64M$803.87M
Diagnostic Solutions$748.89M$697.63M$660.88M$638.76M$460.76M

Qiagen's latest annual revenue breakdown by segment (product or service), as of Dec 24: Diagnostic Solutions (37.86%), Sample Technologies (32.46%), PCR / Nucleic Acid Amplification (15.19%), Genomics / NGS (11.81%), and Product and Service, Other (2.69%).

Qiagen Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21Dec 20
Asia Pacific and Rest of World$298.15M$320.68M$410.29M$429.86M$362.60M
UNITED STATES$942.01M$935.28M$909.62M$909.69M$728.58M
Total Americas$1.03B$1.02B$997.75M$1.01B$825.46M
Other Americas$89.56M$84.77M$88.14M$97.69M$96.88M
EMEA$648.49M$624.57M$733.47M$814.42M$682.29M

Qiagen's latest annual revenue breakdown by geography, as of Dec 24: Total Americas (34.27%), UNITED STATES (31.30%), EMEA (21.55%), Asia Pacific and Rest of World (9.91%), and Other Americas (2.98%).

Qiagen Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IQVIQVIA$15.40B$3.90B
ICLRICON Public$8.12B$2.09B
MEDPMedpace$2.11B$533.32M
QGENQiagen$1.97B$458.80M
NTRANatera$1.70B$439.76M
SHCSotera Health$1.10B$285.47M
NEOGNeogen$924.22M$220.98M
GHGuardant Health$739.02M$177.24M
NEONeoGenomics$660.57M$167.82M
ACRSAclaris Therapeutics$18.72M$4.35M

QGEN Revenue FAQ

What is Qiagen’s yearly revenue?

Qiagen's yearly revenue for 2023 was $1.97B, representing a decrease of -8.23% compared to 2022. The company's yearly revenue for 2022 was $2.14B, representing a decrease of -4.89% compared to 2021. QGEN's yearly revenue for 2021 was $2.25B, representing an increase of 20.39% compared to 2020.

What is Qiagen’s quarterly revenue?

Qiagen's quarterly revenue for Q1 2024 was $458.8M, a -9.89% decrease from the previous quarter (Q4 2023), and a -5.48% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $509.16M, a 6.99% increase from the previous quarter (Q3 2023), and a 2.24% increase year-over-year (Q4 2022). QGEN's quarterly revenue for Q3 2023 was $475.89M, a -3.83% decrease from the previous quarter (Q2 2023), and a -4.75% decrease year-over-year (Q3 2022).

What is Qiagen’s revenue growth rate?

Qiagen's revenue growth rate for the last 3 years (2021-2023) was -12.72%, and for the last 5 years (2019-2023) was 28.75%.

What are Qiagen’s revenue streams?

Qiagen's revenue streams in c 24 are Genomics / NGS, PCR / Nucleic Acid Amplification, Product and Service, Other, Sample Technologies, and Diagnostic Solutions. Genomics / NGS generated $233.61M in revenue, accounting 11.81% of the company's total revenue, down -2.22% year-over-year. PCR / Nucleic Acid Amplification generated $300.47M in revenue, accounting 15.19% of the company's total revenue, up 0.09% year-over-year. Product and Service, Other generated $53.22M in revenue, accounting 2.69% of the company's total revenue, down -18.84% year-over-year. Sample Technologies generated $642.03M in revenue, accounting 32.46% of the company's total revenue, down -3.16% year-over-year. Diagnostic Solutions generated $748.89M in revenue, accounting 37.86% of the company's total revenue, up 7.35% year-over-year.

What is Qiagen’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Qiagen was Diagnostic Solutions. This segment made a revenue of $748.89M, representing 37.86% of the company's total revenue.